The Hamner Institutes and Oslo Cancer Cluster Announce Partnership
Summary
Oslo will bring its highly regarded research and Phase I resources, and potential future access to its own growing European network of collaborators, which includes Heidelberg, Lund, Toulouse, Barcelona and Madrid.The trilateral collaboration among The Hamner, the Oslo Cancer Cluster and China will serve as a vital portal for the pharmaceutical industry to access new discoveries and resources in oncology.The Hamner continues to grow its campus through global partnerships with academia, industry, and government and remains dedicated to positively impacting public health.Oslo will bring its highly regarded research and Phase I resources, and potential future access to its own growing European network of collaborators, which includes Heidelberg, Lund, Toulouse, Barcelona and Madrid.Additionally, The Hamner Accelerator will facilitate the launch of Norwegian bioscience companies – currently numbering among some of the leading innovators in Europe - entering the U.S. market.The Hamner continues to grow its campus through global partnerships with academia, industry, and government and remains dedicated to positively impacting public health.